Search results for: Health Care Systems
Filter search results
OHE Lunchtime Seminar on 19 April 2016: Evidence that challenges decision makers: experiences and examples
29 March 2016
…individual NICE Technology Appraisals are regularly downloaded and used to inform decision making in health care systems in high and middle income countries. Yet NICE is regularly criticised, on the…
What do Pharmaceuticals Really Cost in the Long Run?
6 October 2017
…pharmaceuticals deliver to society in the long run, it is also necessary, at a minimum, to account for any medical cost offsets they generate in health care systems. The…
OHE is Pleased to Announce the Appointment Two New Economists: Marina Rodes Sanchez and Chris Sampson
12 October 2017
…the economics of health care systems in emerging markets. As part of her MSc Marina undertook a summer research placement at OHE, where she studied whether and to what extent…
How to Analyse EQ-5D Data? Methods for Analysing and Reporting EQ-5D Data: The Indispensable New Guide
8 December 2020
…recently – in routine data collection in health care systems. (…) EQ-5D has become the cornerstone of health technology appraisal (HTA), affecting important decisions about access to new medicines. But despite…
The Impact of Health Technology Assessment on Drug Development
3 January 2009
…important snapshot of current industry perspectives on the impact of HTA. Responses show that the pharmaceutical industry is adjusting to the realities of today’s cost conscious health care systems by…
Hospital Acquired Infection
8 January 1997
…primary and secondary care. Given that many health care systems are changing, that lengths of stay are shrinking and that financial accountability is both more transparent and more stringent, it…
OHE responds to the Trump administration’s Executive Order on Drug Prices
14 May 2025
…international value assessment from countries with very different health care systems and opportunity costs. Reference pricing also overlooks the issue of confidential price negotiations between the pharmaceutical industry and individual…
OHE Lunchtime Seminar on Pricing
15 April 2010
…biotechnology industries, consultancies, physicians’ associations, and government. The discussion focussed on value-based pricing for prescription medicines in both market and regulated systems, with comparisons of Sweden and the United States….
OHE at IHEA 2023
9 July 2023, 7:00am
…14:00-14:30 BST The Healthcare System Sustainability and Resilience Index: Estimating the Sustainability and Resilience of Healthcare Systems Poster Session Room 1.42 Graham Cookson and Margherita Neri 10/07/2023 15:30-17:00 SAST /…